234 related articles for article (PubMed ID: 36959614)
1. Anti-signal recognition particle positive necrotizing myopathy-sjogren's syndrome overlap syndrome: a descriptive study on clinical and myopathology features.
Xu L; Yang MG; Hu L; Gao H; Ji S
BMC Musculoskelet Disord; 2023 Mar; 24(1):219. PubMed ID: 36959614
[TBL] [Abstract][Full Text] [Related]
2. [Clinical and pathological characteristics of immune mediated necrotizing myopathy].
Yang HX; Tian XL; Jiang W; Li WL; Liu QY; Peng QL; Wang GC; Lu X
Beijing Da Xue Xue Bao Yi Xue Ban; 2019 Dec; 51(6):989-995. PubMed ID: 31848492
[TBL] [Abstract][Full Text] [Related]
3. [Retrospective study on clinical manifestation, thigh MRI and electrophysiology characteristics of immune-mediated necrotizing myopathy].
Qiao LY; Shi Q; Lin MY; Liu J; Chen ZJ; Pu C
Zhonghua Nei Ke Za Zhi; 2022 Oct; 61(10):1144-1151. PubMed ID: 36207969
[No Abstract] [Full Text] [Related]
4. Immune-mediated necrotizing myopathy (IMNM): A myopathological challenge.
Merlonghi G; Antonini G; Garibaldi M
Autoimmun Rev; 2022 Feb; 21(2):102993. PubMed ID: 34798316
[TBL] [Abstract][Full Text] [Related]
5. Anti-SRP immune-mediated necrotizing myopathy: A critical review of current concepts.
Ma X; Bu BT
Front Immunol; 2022; 13():1019972. PubMed ID: 36311711
[TBL] [Abstract][Full Text] [Related]
6. Belimumab for Immune-Mediated Necrotizing Myopathy Associated With Anti-SRP Antibodies: A Case Report and Retrospective Review of Patients Treated With Anti-B-Cell Therapy in a Single Center and Literature.
Cui BB; Tian YR; Ma XY; Yin G; Xie Q
Front Immunol; 2021; 12():777502. PubMed ID: 34925350
[TBL] [Abstract][Full Text] [Related]
7. Immune-Mediated Necrotizing Myopathy.
Pinal-Fernandez I; Casal-Dominguez M; Mammen AL
Curr Rheumatol Rep; 2018 Mar; 20(4):21. PubMed ID: 29582188
[TBL] [Abstract][Full Text] [Related]
8. Thigh muscle MRI in immune-mediated necrotising myopathy: extensive oedema, early muscle damage and role of anti-SRP autoantibodies as a marker of severity.
Pinal-Fernandez I; Casal-Dominguez M; Carrino JA; Lahouti AH; Basharat P; Albayda J; Paik JJ; Ahlawat S; Danoff SK; Lloyd TE; Mammen AL; Christopher-Stine L
Ann Rheum Dis; 2017 Apr; 76(4):681-687. PubMed ID: 27651398
[TBL] [Abstract][Full Text] [Related]
9. The pathogenesis of anti-signal recognition particle necrotizing myopathy: A Review.
Qiu R; Wang Z; Wei X; Sui H; Jiang Z; Yu XF
Biomed Pharmacother; 2022 Dec; 156():113936. PubMed ID: 36411623
[TBL] [Abstract][Full Text] [Related]
10. Clinical characteristics of myositis patients with isolated anti-U1 ribonucleoprotein antibody resemble immune-mediated necrotizing myopathy.
Ge Y; Yang H; Jiang W; Tian X; Lu X; Wang G
Ther Adv Musculoskelet Dis; 2023; 15():1759720X231181336. PubMed ID: 37465567
[TBL] [Abstract][Full Text] [Related]
11. Perivascular and endomysial macrophages expressing VEGF and CXCL12 promote angiogenesis in anti-HMGCR immune-mediated necrotizing myopathy.
Lia A; Annese T; Fornaro M; Giannini M; D'Abbicco D; Errede M; Lorusso L; Amati A; Tampoia M; Trojano M; Virgintino D; Ribatti D; Serlenga L; Iannone F; Girolamo F
Rheumatology (Oxford); 2022 Aug; 61(8):3448-3460. PubMed ID: 34864921
[TBL] [Abstract][Full Text] [Related]
12. Pathologic Features of Anti-Ku Myositis.
Oyama M; Holzer MT; Ohnuki Y; Saito Y; Nishimori Y; Suzuki S; Shiina T; Leonard-Louis S; Benveniste O; Schneider U; Stenzel W; Nishino I; Suzuki S; Uruha A
Neurology; 2024 Apr; 102(8):e209268. PubMed ID: 38547417
[TBL] [Abstract][Full Text] [Related]
13. The Clinicopathological Distinction Between Seropositive and Seronegative Immune-Mediated Necrotizing Myopathy in China.
Ma X; Xu L; Ji S; Li Y; Bu B
Front Neurol; 2021; 12():670784. PubMed ID: 34290662
[No Abstract] [Full Text] [Related]
14. Immune-mediated necrotizing myopathy: clinical features and pathogenesis.
Allenbach Y; Benveniste O; Stenzel W; Boyer O
Nat Rev Rheumatol; 2020 Dec; 16(12):689-701. PubMed ID: 33093664
[TBL] [Abstract][Full Text] [Related]
15. Thrombotic microangiopathy in a patient with anti-signal recognition particle antibody-positive immune-mediated necrotizing myopathy.
Sakai K; Takahashi M; Ito Y; Yamada S; Ito T; Higuchi Y; Kameda S
Int J Rheum Dis; 2024 Jan; 27(1):e14942. PubMed ID: 37828793
[TBL] [Abstract][Full Text] [Related]
16. Myositis-specific autoantibodies, a cornerstone in immune-mediated necrotizing myopathy.
Anquetil C; Boyer O; Wesner N; Benveniste O; Allenbach Y
Autoimmun Rev; 2019 Mar; 18(3):223-230. PubMed ID: 30639649
[TBL] [Abstract][Full Text] [Related]
17. Influenza A (H3N2) infection followed by anti-signal recognition particle antibody-positive necrotizing myopathy: A case report.
Iriki J; Yamamoto K; Senju H; Nagaoka A; Yoshida M; Iwasaki K; Ashizawa N; Hirayama T; Tashiro M; Takazono T; Imamura Y; Miyazaki T; Izumikawa K; Yanagihara K; Tsujino A; Fukuoka J; Uetani M; Satoh M; Mukae H
Int J Infect Dis; 2021 Feb; 103():33-36. PubMed ID: 33217572
[TBL] [Abstract][Full Text] [Related]
18. Myopathy with anti-signal recognition particle antibodies: clinical and histopathological features in Chinese patients.
Wang L; Liu L; Hao H; Gao F; Liu X; Wang Z; Zhang W; Lv H; Yuan Y
Neuromuscul Disord; 2014 Apr; 24(4):335-41. PubMed ID: 24491486
[TBL] [Abstract][Full Text] [Related]
19. Clinical features and prognosis in anti-SRP and anti-HMGCR necrotising myopathy.
Watanabe Y; Uruha A; Suzuki S; Nakahara J; Hamanaka K; Takayama K; Suzuki N; Nishino I
J Neurol Neurosurg Psychiatry; 2016 Oct; 87(10):1038-44. PubMed ID: 27147697
[TBL] [Abstract][Full Text] [Related]
20. Differences in muscle magnetic resonance imaging findings between anti-signal recognition particle antibody-positive myopathy and anti-aminoacyl-tRNA synthetase antibody-positive myositis.
Kimura M; Aizawa A; Kudou R; Rikitake Y; Iwao C; Rikitake M; Iwao K; Kariya Y; Kawaguchi T; Matsuda M; Miyauchi S; Takajo I; Umekita K
Clin Exp Rheumatol; 2024 Feb; 42(2):321-328. PubMed ID: 37497714
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
